Compare Graham Holdings Company Common Stock (GHC) vs Vaxcyte Inc. Common Stock (PCVX) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Graham Holdings Company Common Stock vs Vaxcyte Inc. Common Stock — how do they compare? Graham Holdings Company Common Stock trades at $1,211.98 (market cap $4.97B), while Vaxcyte Inc. Common Stock trades at $67.27 (market cap $10.51B). The key difference: Vaxcyte Inc. Common Stock is far larger — about 2.1× Graham Holdings Company Common Stock's market cap, and Graham Holdings Company Common Stock pays a 0.64% dividend while Vaxcyte Inc. Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Graham Holdings Company Common Stock for 0 Days and Vaxcyte Inc. Common Stock for 0 Days on average.
| GHC | PCVX | |
|---|---|---|
Market Cap | $4.97B | $10.51B |
Volume | 27,383 | 2,644,694 |
Sector | Industrials | Health |
52-Week High | $1.23K | $73.82 |
52-Week Low | $949.84 | $40.32 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $5.06B | $9.14B |
Dividend Yield | 0.64% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
About Graham Holdings Company Common Stock
Graham Holdings Company is a diversified holding company with operations spanning education services (Kaplan), television broadcasting (Graham Media Group), healthcare services, and manufacturing, among other businesses; it was formerly known as The Washington Post Company.
Read more on GHC →About Vaxcyte Inc. Common Stock
Vaxcyte, Inc. is a clinical-stage vaccine company that engineers protein-based vaccines to prevent bacterial diseases such as invasive pneumococcal disease, using its proprietary cell-free protein synthesis platform to develop candidates including the pneumococcal conjugate vaccines VAX-31 and VAX-24.
Read more on PCVX →
